ACE2基因多态性与原发性高血压的关系

目的 研究血管紧张素转化酶2（angiotensin converting enzyme 2,ACE2）基因多态性与广东地区原发性高血压的相关性.方法 高血压组选择门诊与住院的汉族无血缘关系的原发性高血压369例,男194例,女175例;对照组为同期体检的广东地区健康汉族居民199例,男101例,女98例.排除冠心病、高血压、糖尿病、脑血管病及肝功能不良、肾功能不良.按照性别分为两组,采用病例对照的原则,应用聚合酶链反应和限制性内切酶片段长度多态性（polymerase chain reaction and restriction fragment length polymorphism,PCR-RFLP）的方法检测ACE2基因G9570A多态性,并随机抽取20份标本进行基因测序以核实基因分型.在分析各亚组的年龄、体重指数、血压及生化指标的基础上综合分析ACE2基因多态性与原发性高血压的关系.结果 高血压组G等位基因频率：男75.3%,对照组男60.4%,差异有统计学意义（χ2=7.0086,P=0.0081）,高血压组,女57.4%,对照组45.4%,差异有统计学意义（χ2=6.9443,P=0.0084）;女高血压组GG基因型的频率明显高于对照组（χ2=12.9499,P=0.0015）;G等位基因人群发生高血压的风险高于A等位基因人群,男OR：1.9945,95% CI：1.1916～3.3385,P=0.0082;女OR：1.603,95% CI：1.1274～2.2792,P=0.0085.结论 ACE2-G9570A多态性与原发性高血压相关;携带G等位基因的男性和仅仅携带G基因的女性人群发生高血压的危险性相对较大,提示ACE2基因可作为原发性高血压的候选易感基因.     

中药黄曲霉毒素B1的含量考察

为制定中药ＡＦ－Ｂ１含量限度提供依据。方法：间接竞酶联免疫吸附法。结果：样品ＡＦ－Ｂ１含量在１．１４－３．７２μｇ／ｋｇ之间。结论：制定中药ＡＦ－Ｂ１含量限度是必要的。     

UBE2C promotes the progression of pancreatic cancer and glycolytic activity via EGFR stabilization-mediated PI3K-Akt pathway activation

BackgroundPancreatic cancer (PC) is among the most prevalent and deadliest endocrine tumors, yet the mechanisms governing its pathogenesis remain to be fully clarified. While ubiquitin-conjugating enzyme E2C (UBE2C) has been identified as an important oncogene in several cancers, its importance in PC has yet to be established.MethodsUBE2C expression in PC tumor samples and cell lines was examined via quantitative real-time polymerase chain reaction (qRT-PCR), while appropriate commercial kits were used to assess lactate production, ATP generation, and the uptake of glucose.ResultsUBE2C was found to be upregulated in PC patient tumors and correlated with poorer survival outcomes. In PC cell lines, the silencing of this gene suppressed the malignant activity of cells, thus supporting its identification as an oncogene in this cancer type. Mechanistically, UBE2C was found to promote enhanced matrix metalloproteinase (MMP) protein expression via activating the PI3K-Akt pathway. Moreover, it was found to bind to the epidermal growth factor receptor (EGFR), stabilizing it and driving additional PI3K-Akt pathway activation. UBE2C knockdown in PC cells impaired their uptake of glucose and their ability to produce lactate and ATP.ConclusionsIn conclusion, the results of this study support a role for UBE2C as a driver of metastatic PC progression owing to its ability to bind to EGFR and to induce signaling via the PI3K-Akt pathway.     

基因重组毕赤酵母表达瑞替普酶过程中的酶活性分析

目的 研究毕赤酵母诱导表达瑞替普酶过程中的关键酶活性.方法 以摇瓶培养为研究对象,在用甲醇诱导后,连续取样,破碎菌体制成无细胞悬液,检测乙醇氧化酶、甲醛脱氢酶、PDC、G-6-PD、ID、α-KGD和SD的活性.结果 乙醇氧化酶比活在0～6 h逐渐增加,在第6h达到最大44.5 U/mg蛋白.随后迅速下降.在第24～48 h有所回升,然后又逐渐降低.FAD比活在第0～48h逐渐增加.在第48h达到最大值6.72U/mg蛋白,随后逐渐降低.直至放瓶.G-6-PD比活在第2h～6h逐渐增加,在第6～24h逐渐降低,在第24～48h逐渐升高,48h后又逐渐降低直至放瓶.PDC比活在第0～6h逐渐降低,随后略有升高的趋势.ID、α-KGD、SD的活性变化有相似趋势.在前6 h酶活均迅速下降,在第6～24 h缓慢下降,随后ID活性继续缓慢下降,而α-KGD和SD活性在第2～48 h逐渐升高,在第48 h均达到最高值,然后又逐渐降低,直至放瓶.结论 根据酶活变化规律,可将整个诱导期分为4个阶段:第1阶段为诱导0～6 h,是甲醇适应期;第Ⅱ阶段为诱导6～24h,是快速生长期;第Ⅲ阶段为诱导24～48h,是产物积累期;第Ⅳ阶段为诱导48～72h,是代谢缓慢期.在甲醇适应期,甲醇完全氧化代谢流占主导地位.在快速生长期和产物积累期,代谢流逐渐向糖酵解途径和TCA循环途径迁移.     

胰酶水解干酪素的动力学行为

研究了胰酶水解干酪素制备蛋白胨过程中胰酶在不同温度下的失活行为,以及底物浓度对反应速率和平衡的影响,ｐＨ对反应浓度和平衡的影响。胰酶在４０℃下４ｈ基本不丧失水解大分子的活力;在５０℃,ｍｉｎ、５５℃,１００ｍｉｎ、６０℃,９０ｍｉｎ完全丧失对大分子的水解活性。胰酶短时间在高温下丧失的活性,当其返回到４０℃时可部分恢复。底物和产物对反应有抑制作用。底物初始浓度高,最终平衡转化率低。当ｐＨ８时的反应速     

革兰阴性杆菌去阻遏持续高产AmpC酶检测及耐药性分析

目的:了解近期临床分离的30株革兰氏阴性杆菌去阻遏持续高产AmpC酶情况及对15种抗菌药物的耐药性,并对三种AmpC酶检测方法进行比较,为临床提供常规检测和用药的参考。方法:用头孢西丁药敏法、表型筛选法和三维实验法分别检测AmpC酶,用纸片扩散法进行体外药敏实验。结果:头孢西丁药敏法、表型筛选法和三维实验法的AmpC酶检出率分别为56.7%、13.3%、10.0%,头孢西丁药敏实验与三维实验相比,存在较高假阳性率82.4%,表型筛选法与三维实验符合率达96.7%;17株耐头孢西丁菌株的药敏实验显示出严重的多重耐药,对青霉素类及加β-内酰胺酶抑制剂克拉维酸的复合药物、氨基糖苷类均呈高比例耐药,对加β-内酰胺酶抑制剂舒巴坦和他唑巴坦的头孢菌素类较为敏感,而对亚安培南和头孢肶肟的敏感率达100%。结论:表型筛选法操作简单省时,且准确率高,适合临床推广使用;治疗产AmpC酶菌感染以亚安培南和第四代头孢菌素头孢肶肟较优。     

Changes in liver enzymes and association with prognosis in patients with COVID-19: a retrospective case–control study

ObjectiveCOVID-19 has recently emerged as a serious threat to global health. This study examined the laboratory investigations of patients with COVID-19, with an emphasis on liver enzymes.MethodsThis retrospective, single-center study was performed on patients with COVID-19 who were admitted to Imam Reza Hospital, Iran from March 2020 to February 2021. Laboratory tests included a complete blood cell count, white blood cell (WBC) count, neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), lymphocyte/monocyte ratio, and levels of aspartate aminotransferase, alanine aminotransferase (ALT), and alkaline phosphatase. Patient survival was among the outcome measures investigated in association with laboratory findings.ResultsWe enrolled 77 patients with COVID-19 and 63 healthy controls. In comparison with the control group, patients with COVID-19 showed COVID-19 increased ALT, WBC, neutrophils, NLR, and PLR, and decreased platelet counts and lymphocytes.ConclusionAlthough elevated levels of AST, NLR, PLR, and LMR were found in patients with COVID-19, they were not linked to mortality. Given the presence of AST in other tissues, the influence of SARS-CoV-2 on the liver should be interpreted with caution.